Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease
HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in […]